Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?

For over thirty-five years, available data suggested that therapeutic plasma exchange (TPE) was a useful treatment for patients with Rapidly Progressive Glomerulonephritis (RPGN) associated with ANCA Associated Vasculitis (AAV) and elevated creatinine levels. The publication of the PEXIVAS study has...

Full description

Bibliographic Details
Main Authors: Andre A. Kaplan, Wladimir M. Szpirt
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Kidney and Dialysis
Subjects:
Online Access:https://www.mdpi.com/2673-8236/2/3/35
_version_ 1797464846031126528
author Andre A. Kaplan
Wladimir M. Szpirt
author_facet Andre A. Kaplan
Wladimir M. Szpirt
author_sort Andre A. Kaplan
collection DOAJ
description For over thirty-five years, available data suggested that therapeutic plasma exchange (TPE) was a useful treatment for patients with Rapidly Progressive Glomerulonephritis (RPGN) associated with ANCA Associated Vasculitis (AAV) and elevated creatinine levels. The publication of the PEXIVAS study has challenged this conclusion. This perspective will outline the history of this issue and present our assessment of the current status.
first_indexed 2024-03-09T18:13:57Z
format Article
id doaj.art-929847f754894f25ac886dcc827d6509
institution Directory Open Access Journal
issn 2673-8236
language English
last_indexed 2024-03-09T18:13:57Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Kidney and Dialysis
spelling doaj.art-929847f754894f25ac886dcc827d65092023-11-24T08:54:56ZengMDPI AGKidney and Dialysis2673-82362022-07-012339940610.3390/kidneydial2030035Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?Andre A. Kaplan0Wladimir M. Szpirt1Division of Nephrology, University of Connecticut Health Center, Farmington, CT 06062, USADepartment of Nephrology, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkFor over thirty-five years, available data suggested that therapeutic plasma exchange (TPE) was a useful treatment for patients with Rapidly Progressive Glomerulonephritis (RPGN) associated with ANCA Associated Vasculitis (AAV) and elevated creatinine levels. The publication of the PEXIVAS study has challenged this conclusion. This perspective will outline the history of this issue and present our assessment of the current status.https://www.mdpi.com/2673-8236/2/3/35therapeutic plasma exchangePLEXRPGNANCAPEXIVAS
spellingShingle Andre A. Kaplan
Wladimir M. Szpirt
Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
Kidney and Dialysis
therapeutic plasma exchange
PLEX
RPGN
ANCA
PEXIVAS
title Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
title_full Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
title_fullStr Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
title_full_unstemmed Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
title_short Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
title_sort should we still use therapeutic plasma exchange for rapidly progressive glomerulonephritis in anca associated vasculitis
topic therapeutic plasma exchange
PLEX
RPGN
ANCA
PEXIVAS
url https://www.mdpi.com/2673-8236/2/3/35
work_keys_str_mv AT andreakaplan shouldwestillusetherapeuticplasmaexchangeforrapidlyprogressiveglomerulonephritisinancaassociatedvasculitis
AT wladimirmszpirt shouldwestillusetherapeuticplasmaexchangeforrapidlyprogressiveglomerulonephritisinancaassociatedvasculitis